|
Model Number OP-08W |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
Anaphylactic Shock (1703)
|
Event Date 01/30/2024 |
Event Type
Injury
|
Manufacturer Narrative
|
The complaint prodcut was not analyzed since it was discarded at the hospital.However, we investigated manufacturing and quality control records based on the lot number.According to the investigation, no potential for malfunction was found and no similar event has been reported with this lot number globally so far.Since anaphylactic shock occurred during treatment using the device, it was determined that a causal relationship "cannot be denied." the physician determined this event as "non-serious injury", but we determined this event as "serious injury".Anaphylactic shock is described as anaphylactoid reactions in ifu." e.Precautions 13.Monitor the patient constantly during treatment with the plasmaflo¿ op-05w(a).In the event of any of the following during treatment, immediately ensure the safety of the patient and take appropriate measures in accordance with the directions of the responsible physician.Presence of hemoglobin in separated plasma, due to hemolysis.The other potential reactions due to available substitute fluid such as fresh frozen plasma, plasma protein fraction are anaphylactoid reactions, hypocalcemia and infection." we will continue to monitor the occurrence of similar events carefully.
|
|
Event Description
|
This incident occurred when artificial liver treatment was performed on a patient in china.Plasmaflo op is identical model to op-05w(a) marketed in us.After starting treatment, the patient developed anaphylactic shock symptoms.Artificial liver treatment was stopped, and fluid replacement, vasopressors, and antiallergic drugs were administered to the patient, and the heart rate and blood pressure gradually returned to normal.
|
|
Search Alerts/Recalls
|
|
|